Evidence map›Paper›PMID 29888262›Full record

ArticleBioMed research international2018

HSP90: A Novel Target Gene of miRNA-628-3p in A549 Cells.

Jieli Pan, Fusheng Jiang, Jia Zhou, Dehong Wu, Zhenhua Sheng, Meiya Li

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Urinary biomarkers for lung cancer detection.The journal of liquid biopsy · 2026
    Article
  2. Biochemistry and biophysics reports · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Epigenetic Alterations of Heat Shock Proteins (HSPs) in Cancer.International journal of molecular sciences · 2019
    Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jieli PanAcademy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Fusheng JiangCollege of Life Science, Zhejiang Chinese Medical University, Hangzhou 310053, China.ORCID 0000-0001-5671-4318
Jia ZhouCollege of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Dehong WuThe Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310053, China.
Zhenhua ShengAcademy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Meiya LiAcademy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.ORCID 0000-0002-1251-9550
Zhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer is one of the leading causes of cancer-related death in the world. MicroRNA- (miR-) 628-3p plays critical roles in many cancers, including lung cancer. We investigated how miR-628-3p affected migration and apoptosis in A549 cells. We used bioinformatics algorithms to predict the miR-628-3p target gene to study the molecular mechanism by which miR-628-3p contributes to lung cancer. Then, we used the luciferase reporter assay to identify whether heat shock protein 90a

Indexed as

A549 CellsApoptosisCell MovementCell ProliferationGene Expression Regulation, NeoplasticHSP90 Heat-Shock ProteinsHumansLung NeoplasmsMicroRNAsHSP90 Heat-Shock ProteinsMicroRNAsMIRN628 microRNA, human

Identifiers

PMID29888262
PMCPMC5985115
OpenAlexW2803114140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.